Related Experiment Video
Updated: Jul 18, 2026

Optimization of the Epimedii Folium Mutton-Oil Processing Technology and Testing Its Effect on Zebrafish Embryonic Development
Published on: March 17, 2023
Development of a CZE method for the determination of mizolastine and its impurities in pharmaceutical preparations
Serena Orlandini1, Iacopo Giannini, Roberto Gotti
1Department of Pharmaceutical Sciences, University of Florence, Sesto Fiorentino, Florence, Italy.
Abstract:
A fast and selective CZE method for the determination of mizolastine and related impurities is described. Response surface methodology was applied to study the influence of phosphate/triethanolamine (TEA) buffer concentration, heptakis(2,3,6-tri-O-methyl)-beta-CD (TMbetaCD) concentration, voltage and temperature. The optimum conditions were: 105 mM phosphate/TEA buffer (pH 3.0) containing 10 mM TMbetaCD, temperature 19 degrees C and voltage 30 kV. Validation of the method was performed in drug substance and drug product. Robustness was evaluated using a Plackett-Burman design, including pH among the considered factors. Applying the optimal conditions, the nine peaks were baseline separated in about 10 min. The method was applied to the quality control of mizolastine in controlled-release tablets.
Related Concept Videos
Response Surface Methodology
The process of RSM involves several key steps:
Drug Dissolution: Requirements and Profile Comparison
